Competitive Problems in the Drug Industry Drug Testing

Format:

Book

Government document

Author/Creator:

Library of Congress. Congressional Research Service

Language:

English

Subjects (All):

Administrative law.

Bibliography.

Drugs.

Physical Description:

1 online resource

Contained In:

ProQuest U.S. Congressional Research Digital Collection

Place of Publication:

[Washington, D.C.] [publisher not identified] 1979-1980

Summary:

Appendices (pages 115-142) include bibliography (pages 115-118) and "General Considerations for the Clinical Evaluation of Drugs," FDA, Sept. 1977 (pages 129-142)

Report, prepared by Janet E. Lemke (CRS) in anticipation of 96th Congress consideration of S. 1075, the Drug Regulation Reform Act of 1979, reviewing problems with the FDA system of drug testing and evaluation raised during 1968-69 hearings before the Subcom on Monopoly. Contains update of drug testing issues, including difficulty in selecting an independent investigator to conduct drug tests, substandard quality of drug tests, use of humans in drug tests, and delays in FDA approval of new drugs

Notes:

CRS Report

Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed June 2010). Reuse except for individual research requires license from ProQuest, LLC

Vendor supplied data

Other Format:

Microfiche version Library of Congress. Congressional Research Service. Competitive Problems in the Drug Industry:. 79-S722-15

Publisher Number:

CRS-1979-SPR-0045

Access Restriction:

Restricted for use by site license